3 Promising Penny Stocks With Market Caps Under $3B

Over the last 7 days, the United States market has dropped by 1.1%, yet it remains up by 12% over the past year, with earnings expected to grow annually by 17% in the coming years. Penny stocks may be a throwback term, but they still represent valuable opportunities for investors looking to explore smaller or newer companies that could offer growth at lower price points. By focusing on those with strong balance sheets and solid fundamentals, investors can find hidden gems that might deliver impressive returns without many of the typical risks associated with this segment of the market.

We'll examine a selection from our screener results.

AGNT (AGNT)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: AGNT, Inc, along with its subsidiaries, offers cloud-based real estate brokerage services for residential homeowners and homebuyers, with a market cap of $651.76 million.

Operations: AGNT generates revenue from its North American Realty segment, which accounts for $4.79 billion, and its International Realty segment, contributing $169.48 million, along with Other Affiliated Services at $2.88 million.

Market Cap: $651.76M

AGNT, Inc. operates debt-free with a market cap of US$651.76 million, generating significant revenue from its North American Realty segment at US$4.79 billion and International Realty at US$169.48 million. Despite being unprofitable with increasing losses over the past five years, AGNT trades at a good value compared to peers and is 38.6% below its estimated fair value. Recent guidance indicates expected revenue between US$4.85 billion to US$5.15 billion for 2026 amid macroeconomic challenges, while Q2 2026 sales were reported at US$1,449.55 million with a net loss of US$2.69 million and dividends maintained at $0.05 per share.

• Take a closer look at AGNT's potential here in our financial health report.
• Gain insights into AGNT's future direction by reviewing our growth report.

Quanterix (QTRX)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Quanterix Corporation is a life sciences company operating in North America, Europe, the Middle East, Africa, and the Asia Pacific regions with a market cap of $128.64 million.

Operations: The company generates revenue from its Diagnostic Kits / Equipment segment, totaling $153.41 million.

Market Cap: $128.64M

Quanterix Corporation, with a market cap of US$128.64 million, operates in the life sciences sector and is currently unprofitable, having seen increased losses over the past five years. Despite this, it remains debt-free and has sufficient cash runway for more than a year based on current free cash flow. Recent leadership changes include appointing Dr. Yuri Fesko as Chief Medical Officer to drive innovation in diagnostics. The company reported Q2 2026 revenue of US$32.91 million but lowered its full-year guidance due to revenue shortfalls, signaling challenges amidst efforts to stabilize operations and enhance growth prospects.

• Jump into the full analysis health report here for a deeper understanding of Quanterix.
• Review our growth performance report to gain insights into Quanterix's future.

Under Armour (UAA)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Under Armour, Inc., along with its subsidiaries, is involved in the design, development, marketing, and distribution of performance apparel, footwear, and accessories for men, women, and youth with a market cap of approximately $2.10 billion.

Operations: The company's revenue is primarily derived from North America at $2.80 billion, followed by Europe, The Middle East and Africa (EMEA) at $1.21 billion, Asia-Pacific at $708.33 million, and Latin America at $238.37 million.

Market Cap: $2.1B

Under Armour, with a market cap of US$2.10 billion, is navigating challenges as it remains unprofitable despite a seasoned management team and board. The company experienced a revenue decline in North America and Asia-Pacific, prompting revised guidance for the fiscal year ending March 2027. Short-term assets of US$2.4 billion cover both short- and long-term liabilities, but negative operating cash flow indicates debt coverage issues. Recent strategic moves include filing a shelf registration for securities worth US$101.6 million and launching a collaboration with Dodge to invigorate brand appeal through performance-inspired apparel collections.

• Click here and access our complete financial health analysis report to understand the dynamics of Under Armour.
• Learn about Under Armour's future growth trajectory here.

Next Steps

• Click here to access our complete index of 326 US Penny Stocks.
• Contemplating Other Strategies? Trump has pledged to "unleash" American oil and gas and these 23 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com